TFX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TFX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-04-27), Teleflex's current share price is $206.71. Teleflex's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $59.25. Teleflex's Cyclically Adjusted PS Ratio for today is 3.49.
The historical rank and industry rank for Teleflex's Cyclically Adjusted PS Ratio or its related term are showing as below:
During the past years, Teleflex's highest Cyclically Adjusted PS Ratio was 9.24. The lowest was 1.52. And the median was 4.43.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Teleflex's adjusted revenue per share data for the three months ended in Dec. 2023 was $16.360. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $59.25 for the trailing ten years ended in Dec. 2023.
The historical data trend for Teleflex's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teleflex Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Cyclically Adjusted PS Ratio | Get a 7-Day Free Trial | 4.45 | 4.42 | 4.15 | 3.32 | 4.21 |
For the Medical Instruments & Supplies subindustry, Teleflex's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Teleflex's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Teleflex's Cyclically Adjusted PS Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
Teleflex's Cyclically Adjusted PS Ratio for today is calculated as
Cyclically Adjusted PS Ratio | = | Share Price | / | Cyclically Adjusted Revenue per Share |
= | 206.71 | / | 59.25 | |
= | 3.49 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teleflex's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:
For example, Teleflex's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:
Adj_RevenuePerShare | = | Revenue per Share | / | CPI of Dec. 2023 (Change) | * | Current CPI (Dec. 2023) |
= | 16.36 | / | 129.4194 | * | 129.4194 | |
= | 16.360 |
Current CPI (Dec. 2023) = 129.4194.
Teleflex Quarterly Data
Revenue per Share | CPI | Adj_RevenuePerShare | |
201403 | 9.586 | 99.695 | 12.444 |
201406 | 10.090 | 100.560 | 12.986 |
201409 | 9.805 | 100.428 | 12.636 |
201412 | 10.104 | 99.070 | 13.199 |
201503 | 9.080 | 99.621 | 11.796 |
201506 | 9.402 | 100.684 | 12.085 |
201509 | 9.143 | 100.392 | 11.787 |
201512 | 10.026 | 99.792 | 13.003 |
201603 | 8.710 | 100.470 | 11.220 |
201606 | 10.023 | 101.688 | 12.756 |
201609 | 9.604 | 101.861 | 12.202 |
201612 | 10.909 | 101.863 | 13.860 |
201703 | 10.466 | 102.862 | 13.168 |
201706 | 11.291 | 103.349 | 14.139 |
201709 | 11.478 | 104.136 | 14.265 |
201712 | 12.760 | 104.011 | 15.877 |
201803 | 12.576 | 105.290 | 15.458 |
201806 | 13.380 | 106.317 | 16.287 |
201809 | 13.023 | 106.507 | 15.825 |
201812 | 13.695 | 105.998 | 16.721 |
201903 | 13.071 | 107.251 | 15.773 |
201906 | 13.873 | 108.070 | 16.614 |
201909 | 13.743 | 108.329 | 16.419 |
201912 | 14.425 | 108.420 | 17.219 |
202003 | 13.352 | 108.902 | 15.868 |
202006 | 12.003 | 108.767 | 14.282 |
202009 | 13.274 | 109.815 | 15.644 |
202012 | 15.022 | 109.897 | 17.691 |
202103 | 13.372 | 111.754 | 15.486 |
202106 | 15.042 | 114.631 | 16.982 |
202109 | 14.757 | 115.734 | 16.502 |
202112 | 16.069 | 117.630 | 17.680 |
202203 | 13.538 | 121.301 | 14.444 |
202206 | 14.880 | 125.017 | 15.404 |
202209 | 14.531 | 125.227 | 15.018 |
202212 | 16.051 | 125.222 | 16.589 |
202303 | 15.035 | 127.348 | 15.280 |
202306 | 15.704 | 128.729 | 15.788 |
202309 | 15.780 | 129.860 | 15.727 |
202312 | 16.360 | 129.419 | 16.360 |
Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Thank you for viewing the detailed overview of Teleflex's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Liam Kelly | officer: EVP & President, International | IDA BUSINESS AND TECHNOLOGY PARK, DUBLIN ROAD, ATHLONE L2 00000 |
Thomas E Powell | officer: Senior Vice President & CFO | C/O TOMOTHERAPY INCORPORATED, 1240 DEMING WAY, MADISON WI 53717 |
Stuart A Randle | director | 585 WEST 500 SOUTH, BOUNTIFUL UT 84010 |
Jaewon Ryu | director | 950 N. GLEBE ROAD, SUITE 700, ARLINGTON VA 22203 |
Neena M Patil | director | JAZZ PHARMACEUTICALS, 3170 PORTER DRIVE, PALO ALTO CA 94304 |
Andrew A Krakauer | director | CANTEL MEDICAL CORP., 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424 |
Cameron P Hicks | officer: Vice President, Global HR | 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087 |
Klasko Stephen K. M.d. | director | 155 SOUTH LIMERICK ROAD, LIMERICK PA 19468 |
Jay White | officer: VP & Pres, Global Commercial | 3015 CARRINGTON MILL BLVD., MORRISVILLE NC 27560 |
Daniel V. Logue | officer: VP, Gen Counsel & Secretary | 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087 |
John Deren | officer: VP & Chief Accounting Officer | 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087 |
James J Leyden | officer: VP, General Counsel, Secretary | C/O INFRASOURCE SERVICES, INC, 500 WEST DUTTON MILL ROAD, ASTON PA 19014 |
James Winters | officer: Vice President, Mfg and Supply | 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087 |
Mario Wijker | officer: Vice President, QARA | 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087 |
Benson Smith | director | C/O ROCHESTER MEDICAL INC, ONE ROCHESTER MEDICAL DDRIVE, STEWARTVILLE MN 55976 |
From GuruFocus
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024